Drug Manufacturers - Specialty & Generic
BIOA
5.35
price down icon1.83%   -0.10
after-market Handel nachbörslich: 5.12 -0.23 -4.30%

Bioage Labs Inc (BIOA)
full-star
loading
Überblick Nachrichten Preisverlauf Forum Prognose
Schlusskurs vom Vortag:
$5.45
Offen:
$5.46
24-Stunden-Volumen:
505.31K
Relative Volume:
3.65
Marktkapitalisierung:
$191.80M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-4.63%
1M Leistung:
+11.00%
6M Leistung:
+55.98%
1J Leistung:
-73.95%
1-Tages-Spanne:
Value
$5.245
$5.46
1-Wochen-Bereich:
Value
$5.245
$5.80
52-Wochen-Spanne:
Value
$2.88
$26.62

Bioage Labs Inc Stock (BIOA) Company Profile

Name
Firmenname
Bioage Labs Inc
Name
Sektor
Healthcare (1141)
Name
Branche
Drug Manufacturers - Specialty & Generic (83)
Name
Telefon
510-806-1445
Name
Adresse
5885 HOLLIS STREET, EMERYVILLE
Name
Mitarbeiter
64
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
BIOA's Discussions on Twitter

Vergleichen Sie BIOA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
BIOA
Bioage Labs Inc
 5.35 195.38M 0 0 0 0.00
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
 141.11 63.55B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
 13.71 44.47B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
 9.00 40.17B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
 20.03 22.99B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
 440.00 20.14B 3.08B 1.24B 1.07B 25.61

Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-28 Eingeleitet William Blair Mkt Perform
2024-12-10 Herabstufung Morgan Stanley Overweight → Underweight
2024-12-09 Herabstufung Citigroup Buy → Neutral
2024-12-09 Herabstufung Jefferies Buy → Hold
2024-10-21 Eingeleitet Citigroup Buy
2024-10-21 Eingeleitet Jefferies Buy
2024-10-21 Eingeleitet Morgan Stanley Overweight
Alle ansehen

Bioage Labs Inc Aktie (BIOA) Neueste Nachrichten

pulisher
Oct 09, 2025

Short interest data insights for BioAge Labs Inc.2025 Volume Leaders & Accurate Technical Buy Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

BioAge Labs (NASDAQ:BIOA) Given Sell (E+) Rating at Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 06, 2025

Can BioAge Labs Inc. stock sustain revenue growthPortfolio Return Summary & Real-Time Volume Analysis Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Can trapped investors hope for a rebound in BioAge Labs Inc.2025 Analyst Calls & Growth Focused Entry Reports - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

What drives BioAge Labs Inc stock priceEarnings Surprise Analysis & Minimal Investment Trading - earlytimes.in

Oct 05, 2025
pulisher
Oct 05, 2025

Developing predictive dashboards with BioAge Labs Inc. data2025 Key Lessons & Weekly Top Gainers Trade List - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Can momentum traders help lift BioAge Labs Inc.M&A Rumor & Weekly High Conviction Ideas - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Using Ichimoku Cloud for BioAge Labs Inc. technicals2025 Top Gainers & Low Risk Entry Point Guides - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Will BioAge Labs Inc. stock outperform tech sector in 20252025 Geopolitical Influence & Capital Protection Trading Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

How strong is BioAge Labs Inc. (Y7G) stock earnings growth2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Analyzing net buyer seller activity in BioAge Labs Inc.Market Rally & Low Drawdown Investment Ideas - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

BIOAGE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire

Oct 03, 2025
pulisher
Oct 03, 2025

How high can BioAge Labs Inc. stock go2025 Buyback Activity & Precise Buy Zone Tips - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

BioAge Labs files for mixed shelf offering of up to $250 millionSEC filing - MarketScreener

Oct 02, 2025
pulisher
Oct 02, 2025

BioAge Labs Files $250 Million Mixed Shelf - MarketScreener

Oct 02, 2025
pulisher
Oct 01, 2025

Is BioAge Labs Inc a good long term investmentStock Valuation Metrics & Your Free Entry to Smart Investing Starts Here - earlytimes.in

Oct 01, 2025
pulisher
Oct 01, 2025

What analysts say about BioAge Labs Inc Y7G stockMarket Capitalization Trends & Reap the Rewards of Patience + Planning - earlytimes.in

Oct 01, 2025
pulisher
Oct 01, 2025

BioAge Labs Inc Y7G Stock Analysis and ForecastFibonacci Extensions & Build Winning Portfolio - earlytimes.in

Oct 01, 2025
pulisher
Sep 27, 2025

BioAge Labs, Inc. (NASDAQ:BIOA) institutional owners may be pleased with recent gains after 74% loss over the past year - simplywall.st

Sep 27, 2025

Finanzdaten der Bioage Labs Inc-Aktie (BIOA)

Es liegen keine Finanzdaten für Bioage Labs Inc (BIOA) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie BIOA

drug_manufacturers_specialty_generic ELAN
$19.76
price down icon 1.54%
drug_manufacturers_specialty_generic VTRS
$9.74
price down icon 2.50%
drug_manufacturers_specialty_generic HIMS
$53.95
price down icon 7.38%
drug_manufacturers_specialty_generic RDY
$14.34
price up icon 1.20%
drug_manufacturers_specialty_generic NBIX
$136.63
price down icon 1.33%
drug_manufacturers_specialty_generic UTHR
$440.00
price down icon 1.21%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):